We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$31.9B
AUM Growth
+$2.38B
Cap. Flow
+$1.7B
Cap. Flow %
5.32%
Top 10 Hldgs %
15.42%
Holding
3,195
New
265
Increased
1,619
Reduced
1,032
Closed
182

Sector Composition

Rank Sector Weight
1 Healthcare 9.59%
2 Technology 8.36%
3 Consumer Staples 8.04%
4 Financials 7.78%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.B
401
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$15.1M 0.05%
269,077
+34,308
+15% +$1.76M
AGU
402
DELISTED
Agrium
AGU
$15M 0.05%
165,988
+35,853
+28% +$3.19M
IWP icon
403
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$14.9M 0.05%
318,938
-4,298
-1% -$199K
LSTR icon
404
Landstar System
LSTR
$6.01B
$14.8M 0.05%
216,267
+14,204
+7% +$938K
AJG icon
405
Arthur J. Gallagher & Co
AJG
$64.5B
$14.8M 0.05%
311,799
+15,683
+5% +$728K
FLG
406
Flagstar Bank National Association
FLG
$5.9B
$14.7M 0.05%
327,143
+8,532
+3% +$389K
IHI icon
407
iShares US Medical Devices ETF
IHI
$3.36B
$14.7M 0.05%
651,138
+33,078
+5% +$716K
ZTS icon
408
Zoetis
ZTS
$32.4B
$14.7M 0.05%
309,574
+34,049
+12% +$1.61M
PBCT
409
DELISTED
People's United Financial Inc
PBCT
$14.7M 0.05%
999,582
+34,515
+4% +$536K
CHRW icon
410
C.H. Robinson
CHRW
$17.1B
$14.6M 0.05%
196,750
+27,388
+16% +$2M
PUK icon
411
Prudential
PUK
$34.7B
$14.5M 0.05%
440,281
+4,110
+0.9% +$151K
BSX icon
412
Boston Scientific
BSX
$71.4B
$14.5M 0.05%
620,352
+143,017
+30% +$3.09M
AMAT icon
413
Applied Materials
AMAT
$419B
$14.5M 0.05%
603,548
+289,023
+92% +$6.38M
MAR icon
414
Marriott International
MAR
$93.8B
$14.3M 0.04%
215,130
+51,071
+31% +$3.43M
TE
415
DELISTED
TECO ENERGY INC
TE
$14.3M 0.04%
516,787
-144,420
-22% -$3.99M
AFL icon
416
Aflac
AFL
$64.5B
$14.2M 0.04%
394,942
+66,458
+20% +$2.27M
IJT icon
417
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.38B
$14.2M 0.04%
221,748
+21,446
+11% +$1.35M
BX icon
418
Blackstone
BX
$107B
$14.2M 0.04%
579,386
+54,737
+10% +$1.46M
LEA icon
419
Lear
LEA
$7.93B
$14.2M 0.04%
139,538
-52,195
-27% -$5.87M
RSG icon
420
Republic Services
RSG
$64.5B
$14.2M 0.04%
276,130
-533,243
-66% -$25.6M
FANG icon
421
Diamondback Energy
FANG
$53.1B
$14.1M 0.04%
154,811
+16,099
+12% +$1.39M
DOX icon
422
Amdocs
DOX
$6.28B
$14.1M 0.04%
244,509
+13,906
+6% +$797K
UBS icon
423
UBS Group
UBS
$173B
$14.1M 0.04%
1,093,361
+92,756
+9% +$1.42M
MRSH
424
Marsh
MRSH
$92.2B
$14.1M 0.04%
205,409
+12,911
+7% +$829K
TMO icon
425
Thermo Fisher Scientific
TMO
$214B
$14M 0.04%
94,958
+5,134
+6% +$758K

Similar funds

Raymond James & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Raymond James & Associates held 3,195 positions worth $31.9B, up 8.1% from $29.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.7B of net new capital in Q2 2016, opening 265 new positions and adding to 1,619 existing holdings. Its largest new stake was Schwab US REIT ETF: 467,710 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.6% of assets, up from 9% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was WisdomTree Europe Hedged Equity Fund, an estimated $43.1M trimmed.

  • Raymond James & Associates's largest Q2 2016 buy was Schwab US REIT ETF: 467,710 shares worth $10.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2016, an estimated $107M increase.
  • Raymond James & Associates's biggest Q2 2016 reduction was WisdomTree Europe Hedged Equity Fund, cutting an estimated $43.1M.
  • Raymond James & Associates fully exited ADT Corp in Q2 2016, selling an estimated $34.4M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $31.9B portfolio in Q2 2016.
  • Raymond James & Associates opened 265 new positions and closed 182 in Q2 2016.
  • Raymond James & Associates's portfolio value rose 8.1% quarter-over-quarter to $31.9B.

Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.